ITW Shorts Retreat After Q3 Results
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Illinois Tool Works reported its third-quarter results on October 27, and the clearest market reaction since is not in the share price but in the lending market, where short sellers have been pulling back at an unusually sharp pace.
Short positions dropped 6.1% over the past week to 2.88% of free float, or roughly 8.35 million shares. That weekly decline is about 1.6 standard deviations steeper than the typical weekly move for ITW over the past year, making it one of the more decisive short-side retreats in recent months. The cost to borrow has also eased, falling 6.9% on the week to 0.42%, the lowest it has been since early October. Availability remains exceptionally loose at 2,533%, meaning there are more than 25 shares available to lend for every one currently borrowed. None of this suggests a crowded short book: with positions at less than 3% of the float and borrow costs barely above zero, the short side of ITW has never been more than a minor part of the story.
Options positioning reflects a similar lack of urgency on the downside. The put/call ratio has drifted to 0.38, slightly below its 20-day average of 0.41 and about 0.6 standard deviations below the mean. That puts it well within the calm end of its 52-week range, which runs from 0.20 to 0.73. Call volume is modestly outpacing put volume, but not by enough to read as directional conviction. The overall positioning picture is quiet rather than charged.
The analyst picture has shifted modestly following the Q3 print. Truist Securities trimmed its target to $293 from $297 on October 28, reiterating a Hold. That follows JP Morgan's more consequential move earlier this month, when the bank cut its rating from Overweight to Neutral and slashed its target from $350 to $277. The consensus has settled at Hold across all 11 covering analysts, with a mean target of $294.50, about 6.7% above the October 27 close of $275.93. The stock trades at a price/earnings multiple of 22.6x and an EV/EBITDA of 16.9x. The factor profile shows an above-average forward earnings revision score (72nd percentile on 12-month forward EPS growth) but weak near-term EPS momentum, ranking in the 23rd percentile on the 30-day measure. The dividend score is exceptionally strong at the 97th percentile, consistent with ITW's track record as a capital returns story.
The share price itself barely moved on the week, up 0.3% to $275.93. That modest gain stands against a median decline of 2.5% among its closest industrial peers. Xylem was the notable laggard in the group, falling 11.6% on the week. Fortive and Stanley Black and Decker both added roughly 5.6%. ITW's relative steadiness after an earnings print that had drawn significant pre-announcement caution from JP Morgan is the more interesting data point than the magnitude of the move itself.
Wikipedia page views for ITW are running at a z-score of 1.67 against the company's own 90-day history, suggesting retail attention to the name has ticked up around the Q3 release. The next earnings event is not until February 1, 2027, leaving a 96-day gap in which the key variables to track are whether the short book continues to compress, and whether the gap between the current price and the $294.50 consensus target narrows through analyst revisions or price movement.
Stocks in this article
See the live data behind this article on ORTEX.
Open ITW on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 18:22
- Data as of
- 28 Oct 2026, 18:17
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
- Validation notes
- soft: missing section mentions: short interest (informational only)
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.